Global Automated Antimicrobial Susceptibility Testing Market Size By Type (Consumables, Instruments), By Application (Pharmaceutical and Biotechnology Companies, Contract Research Organizations), By R...

The Global Automated Antimicrobial Susceptibility Testing Market was valued at USD 4.8 billion in 2023 and is projected to surpass USD 9.6 billion by 2031, growing at a CAGR of 9.1% during the forecast period from 2023 to 2031.

The increasing burden of antimicrobial resistance (AMR) is a major driver fueling the demand for automated antimicrobial susceptibility testing (AST) systems. The need for rapid, accurate, and efficient diagnostic solutions to guide targeted antimicrobial therapy has led to a surge in the adoption of automated AST devices. Advancements in microfluidics, AI-driven diagnostics, and lab automation are further propelling market growth.

Additionally, the growing investments in clinical microbiology laboratories, rising healthcare expenditure, and government initiatives aimed at combating AMR are fostering the expansion of the automated AST market worldwide.

Market Drivers

✅ Rising Prevalence of Antimicrobial Resistance (AMR)

The increasing occurrence of drug-resistant infections is a major concern globally. Automated AST systems play a crucial role in identifying resistant strains efficiently, allowing healthcare professionals to prescribe effective antibiotics.

✅ Advancements in AST Technologies

The development of high-throughput, AI-powered, and automated AST devices enhances diagnostic accuracy and speeds up clinical decision-making. Integration with Laboratory Information Systems (LIS) and Electronic Health Records (EHRs) further streamlines workflow.

✅ Growing Demand for Precision Medicine

With the shift towards personalized medicine, healthcare providers are increasingly relying on precise, automated AST solutions to select targeted antimicrobial therapies, reducing unnecessary antibiotic use and improving patient outcomes.

Market Restraints

❌ High Costs of Automated AST Systems

The initial capital investment and maintenance costs of automated AST devices pose a challenge, particularly for small and mid-sized clinical laboratories in low-income regions.

❌ Regulatory and Compliance Challenges

The stringent regulatory approvals required for AST systems and antimicrobial susceptibility assays can delay product launches and hinder market growth.

Market Opportunity

💡 Expansion of AST Systems in Emerging Markets

Developing nations, especially in Asia-Pacific and Latin America, are witnessing increased investments in clinical microbiology labs. The expansion of healthcare infrastructure provides lucrative opportunities for market players.

💡 Integration of AI and Machine Learning in AST

The incorporation of artificial intelligence and machine learning algorithms into AST systems is enabling faster and more accurate pathogen identification, improving overall diagnostic efficiency.

Market by System Type Insights

📌 The Fully Automated AST Systems segment dominated the market in 2023, holding the largest revenue share. These systems offer rapid turnaround times, high throughput, and reduced human error, making them the preferred choice in large reference labs and hospitals.

📌 The Semi-Automated AST Systems segment is expected to witness significant growth, particularly in cost-sensitive regions, where manual methods are still widely used but transitioning towards automation.

Market by End-Use Insights

🏥 Hospitals & Diagnostic Laboratories accounted for more than 55% of the market share in 2023, driven by the rising demand for rapid AST in clinical settings for critical patient management.

🔬 Pharmaceutical & Biotechnology Companies are also significant end-users, leveraging automated AST technologies for antibiotic development and clinical trials.

Market by Regional Insights

🌎 North America led the market in 2023, accounting for the largest share, owing to strong healthcare infrastructure, high AMR prevalence, and increased adoption of automated AST solutions.

🌏 Asia-Pacific is expected to witness the fastest growth rate, driven by government funding for antimicrobial resistance surveillance programs, increasing healthcare investments, and rising laboratory automation adoption in China, India, and Japan.

Competitive Scenario

Key players in the Global Automated Antimicrobial Susceptibility Testing Market include:

🔹 bioMérieux SA

🔹 Becton, Dickinson and Company (BD)

🔹 Thermo Fisher Scientific Inc.

🔹 Danaher Corporation (Beckman Coulter)

🔹 Merck KGaA (MilliporeSigma)

🔹 Bruker Corporation

🔹 Accelerate Diagnostics, Inc.

🔹 Luminex Corporation

These companies focus on R&D investments, strategic partnerships, product innovations, and geographic expansions to strengthen their market position.

📢 Recent Developments:

🔹 In 2023, bioMérieux launched an AI-powered automated AST platform that reduces test turnaround time by 40%.

🔹 Thermo Fisher Scientific introduced a next-gen AST system integrated with cloud-based data analytics for enhanced precision.

Scope of Work – Global Automated Antimicrobial Susceptibility Testing Market

Report Metric Details

Market Size (2023) USD 4.8 billion

Projected Market Size (2031) USD 9.6 billion

CAGR (2023-2031) 9.1%

Key Segments By System Type (Fully Automated, Semi-Automated), By End-Use (Hospitals, Diagnostic Labs, Pharma Companies), By Region

Growth Drivers Rising AMR Cases, Lab Automation, AI-Driven AST Technologies

Opportunities Emerging Markets, AI-Powered Diagnostics, Cloud-Based AST Systems

FAQs

1. What is the current market size of the Global Automated Antimicrobial Susceptibility Testing Market?

The market was valued at USD 4.8 billion in 2023.

2. What is the major growth driver of the Global Automated Antimicrobial Susceptibility Testing Market?

The increasing prevalence of antimicrobial resistance (AMR) and the growing adoption of automated AST solutions in clinical settings are key growth drivers.

3. Which is the largest region during the forecast period in the Global Automated Antimicrobial Susceptibility Testing Market?

North America is the largest region, while Asia-Pacific is expected to grow at the fastest rate due to increasing investments in laboratory automation.

4. Which segment accounted for the largest market share in the Global Automated Antimicrobial Susceptibility Testing Market?

The Fully Automated AST Systems segment accounted for the largest market share in 2023 due to its high efficiency, accuracy, and speed.

5. Who are the key market players in the Global Automated Antimicrobial Susceptibility Testing Market?

Key players include bioMérieux, BD, Thermo Fisher Scientific, Danaher, Merck KGaA, Bruker, Accelerate Diagnostics, and Luminex Corporation.

This comprehensive and data-driven market report provides a detailed analysis of the Global Automated Antimicrobial Susceptibility Testing Market, covering market trends, drivers, opportunities, competitive landscape, and future growth potential. 🚀